CymaBay Therapeutics, Inc.
Extract: Bylaws Amendment (Plain English Desc) from a 8-K on 02/12/2024   Download
SEC Document
SEC Filing

On February 11, 2024, the Board adopted an amendment (the “Amendment”) to the Company’s bylaws (as may be amended from time to time, the “Bylaws”), which became effective immediately. The Amendment added a new Article XV to the Bylaws which provides that, unless the Company consents in writing to the selection of an alternative forum, (i) the sole and exclusive forum for certain legal actions involving the Company will be the Delaware Court of Chancery (or, in the event that the Delaware Court of Chancery lacks subject matter jurisdiction over any such actions, another state or federal court located within the State of Delaware) and (ii) the sole and exclusive forum for certain legal actions arising under the Securities Act of 1933, as amended (the “Securities Act”), the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or for which there is exclusive federal or concurrent federal or state jurisdiction, in each case, shall, to the fullest extent permitted by applicable law, be the federal district courts of the United States of America.